Enovis director granted 9,346 company shares

Shirley Brady reported acquisition or exercise transactions in this Form 4 filing.

Rhea-AI Filing Summary

Shirley Brady reported acquisition or exercise transactions in this Form 4 filing.

Enovis CORP director Shirley Brady received a grant of 9,346 shares of common stock on May 19, 2026. The shares were awarded at no stated price as compensation rather than a market purchase. After this award, Brady directly holds a total of 110,589 Enovis common shares.

Insights

Equity compensation analyst

Director received routine stock grant, increasing direct stake modestly.

Director Shirley Brady was granted 9,346 shares of Enovis CORP common stock as a compensation award, not an open-market purchase. The filing shows no associated sales or derivative exercises, indicating a straightforward equity grant.

Following the grant, Brady directly holds 110,589 common shares. This type of award is a common board compensation tool and, based on the data provided, represents a modest increase in her ownership rather than a large, thesis-changing transaction.

Insider Trade Summary

Grant/Award: 9,346 shares

Grant/Award 1 txn

Insider Shirley Brady

Role Director

Type	Security	Shares	Price	Value
Grant/Award	Common stock, par value $0.001	9,346	$0.00	$0.00

Holdings After Transaction: Common stock, par value $0.001 — 110,589 shares (Direct)

Key Figures

Shares granted: 9,346 shares Grant price: $0.00 per share Shares owned after: 110,589 shares +1 more

4 metrics

Shares granted 9,346 shares Common stock grant on May 19, 2026

Grant price $0.00 per share Recorded price for stock award

Shares owned after 110,589 shares Total direct holdings following transaction

Transaction code A Grant, award, or other acquisition of common stock

Key Terms

Common stock, par value $0.001, Grant, award, or other acquisition, Form 4, transaction_code "A"

4 terms

Common stock, par value $0.001 financial

"security_title: Common stock, par value $0.001"

Grant, award, or other acquisition financial

"transaction_code_description: Grant, award, or other acquisition"

Form 4 regulatory

"INSIDER FILING DATA (Form 4)"

Form 4 is a official document that company insiders, such as executives or major shareholders, file with regulators whenever they buy or sell company shares. It provides transparency about how those with inside knowledge are trading, helping investors see if insiders are confident in the company's prospects or may be selling for personal reasons. This information can influence investor decisions by revealing insiders' perspectives on the company's value.

transaction_code "A" regulatory

"transaction_code: "A""

FAQ

AI-generated questions and answers. How Rhea-AI works. Not financial advice.

What insider transaction did Enovis (ENOV) director Shirley Brady report?

Enovis director Shirley Brady reported receiving a grant of 9,346 shares of common stock. The award was recorded at a price of $0.00 per share, reflecting a compensation grant rather than an open-market purchase, and increased her direct shareholdings in the company.

How many Enovis (ENOV) shares does Shirley Brady own after this Form 4?

After the reported grant, Shirley Brady directly holds 110,589 shares of Enovis common stock. This total reflects her position following the award of 9,346 shares on May 19, 2026, and shows her ongoing equity exposure as a board member of the company.

Was the Enovis (ENOV) Form 4 transaction a stock purchase or a grant?

The Form 4 reports a stock grant, not a market purchase. Transaction code "A" and a $0.00 per-share price indicate a “grant, award, or other acquisition” of 9,346 Enovis common shares provided as compensation rather than shares bought in the open market.

Does the Enovis (ENOV) Form 4 show any stock sales by Shirley Brady?

The filing shows no stock sales by Shirley Brady. It reports only one acquisition transaction: a grant of 9,346 Enovis common shares. Transaction summaries list no sell, exercise, gift, or tax-withholding entries, indicating no dispositions in this particular Form 4.

Is the Enovis (ENOV) insider transaction part of an options exercise?

No option exercise is shown in this Form 4. The transaction is coded "A" as a direct grant or award of 9,346 common shares, with derivative transaction counts listed as zero, indicating no option, warrant, or other derivative exercises in this disclosure.

How significant is Shirley Brady’s Enovis (ENOV) stock grant for investors?

The grant increases Shirley Brady’s direct holdings to 110,589 shares, but remains a typical director equity award. It reflects ongoing alignment between board compensation and shareholder interests, without indicating a large discretionary buy or sell decision that would materially shift investor views.

AI-generated analysis. How Rhea-AI works. Not financial advice.

Form 4 Insider Transactions: What Each Field Means →

See more from StockTitan in Google Search and AI answers. Adds StockTitan as a preferred source · opens Google

Add on Google Not now

Accepted by SEC EDGAR 05/21/2026 - 08:30 PM EDT Learn about SEC filing dates

SEC Form 4

FORM 4

UNITED STATES SECURITIES AND EXCHANGE COMMISSION
Washington, D.C. 20549

STATEMENT OF CHANGES IN BENEFICIAL OWNERSHIP

Filed pursuant to Section 16(a) of the Securities Exchange Act of 1934
or Section 30(h) of the Investment Company Act of 1940

OMB APPROVAL

OMB Number:			3235-0287
Estimated average burden
hours per response:			0.5

Check this box if no longer subject to Section 16. Form 4 or Form 5 obligations may continue. See Instruction 1(b).

Check this box to indicate that a transaction was made pursuant to a contract, instruction or written plan for the purchase or sale of equity securities of the issuer that is intended to satisfy the affirmative defense conditions of Rule 10b5-1(c). See Instruction 10.

1. Name and Address of Reporting Person^*

Shirley Brady

(Last) (First) (Middle)

2711 CENTERVILLE ROAD

SUITE 400

(Street)

WILMINGTON DELAWARE 19808

(City) (State) (Zip)

UNITED STATES

(Country)

2. Issuer Name and Ticker or Trading Symbol
Enovis CORP [ ENOV ]

5. Relationship of Reporting Person(s) to Issuer
(Check all applicable)

X	Director		10% Owner
	Officer (give title below)		Other (specify below)

2a. Foreign Trading Symbol

3. Date of Earliest Transaction (Month/Day/Year)
05/19/2026

6. Individual or Joint/Group Filing (Check Applicable Line)

X	Form filed by One Reporting Person
	Form filed by More than One Reporting Person

4. If Amendment, Date of Original Filed (Month/Day/Year)

Table I - Non-Derivative Securities Acquired, Disposed of, or Beneficially Owned
1. Title of Security (Instr. 3)	2. Transaction Date (Month/Day/Year)	2A. Deemed Execution Date, if any (Month/Day/Year)	3. Transaction Code (Instr. 8)		4. Securities Acquired (A) or Disposed Of (D) (Instr. 3, 4 and 5)			5. Amount of Securities Beneficially Owned Following Reported Transaction(s) (Instr. 3 and 4)	6. Ownership Form: Direct (D) or Indirect (I) (Instr. 4)	7. Nature of Indirect Beneficial Ownership (Instr. 4)
			Code	V	Amount	(A) or (D)	Price
Common stock, par value $0.001	05/19/2026		A		9,346	A	$0.00	110,589	D

Table II - Derivative Securities Acquired, Disposed of, or Beneficially Owned (e.g., puts, calls, warrants, options, convertible securities)
1. Title of Derivative Security (Instr. 3)	2. Conversion or Exercise Price of Derivative Security	3. Transaction Date (Month/Day/Year)	3A. Deemed Execution Date, if any (Month/Day/Year)	4. Transaction Code (Instr. 8)		5. Number of Derivative Securities Acquired (A) or Disposed of (D) (Instr. 3, 4 and 5)		6. Date Exercisable and Expiration Date (Month/Day/Year)		7. Title and Amount of Securities Underlying Derivative Security (Instr. 3 and 4)		8. Price of Derivative Security (Instr. 5)	9. Number of derivative Securities Beneficially Owned Following Reported Transaction(s) (Instr. 4)	10. Ownership Form: Direct (D) or Indirect (I) (Instr. 4)	11. Nature of Indirect Beneficial Ownership (Instr. 4)
				Code	V	(A)	(D)	Date Exercisable	Expiration Date	Title	Amount or Number of Shares

Explanation of Responses:

	/s/ Brian P. Hanigan, attorney-in-fact	05/21/2026
	** Signature of Reporting Person	Date
Reminder: Report on a separate line for each class of securities beneficially owned directly or indirectly.
* If the form is filed by more than one reporting person, see Instruction 4 (b)(v).
** Intentional misstatements or omissions of facts constitute Federal Criminal Violations See 18 U.S.C. 1001 and 15 U.S.C. 78ff(a).
Note: File three copies of this Form, one of which must be manually signed. If space is insufficient, see Instruction 6 for procedure.
Persons who respond to the collection of information contained in this form are not required to respond unless the form displays a currently valid OMB Number.
* Form 4: SEC 1474 (03-26)